Can You Take Lamictal (Lamotrigine) with Bradycardia?
Yes, you can generally take lamotrigine if you have bradycardia, as the drug does not appear to cause or worsen bradycardia based on current evidence. However, if you have underlying structural heart disease or conduction system disease in addition to bradycardia, closer cardiac monitoring is warranted.
Key Evidence from FDA Drug Label
The FDA label for lamotrigine explicitly addresses cardiac effects 1:
- Lamotrigine exhibits Class IB antiarrhythmic activity at therapeutic concentrations, inhibiting cardiac sodium channels
- In healthy individuals, therapeutic doses did not slow ventricular conduction (widen QRS) in thorough QT studies
- The warning applies specifically to patients with: heart failure, valvular heart disease, congenital heart disease, conduction system disease, ventricular arrhythmias, cardiac channelopathies, or ischemic heart disease
- The concern is about ventricular conduction slowing and proarrhythmia, not bradycardia
What the Research Shows About Bradycardia
The evidence regarding lamotrigine and bradycardia is reassuring:
- A large FDA adverse event database analysis found significantly lower reporting risk for bradyarrhythmia with lamotrigine in epilepsy patients (adjusted ROR 0.45,95% CI 0.29-0.68) 2
- A Danish population study of 91,949 lamotrigine users found no association with cardiac conduction disorders (HR 1.03,95% CI 0.76-1.40) 3
- A systematic review found insufficient evidence that lamotrigine causes sudden death or ECG changes, with most studies showing no significant risk 4
While one case report described sinus bradycardia in an adolescent taking lamotrigine 5, this represents an isolated observation rather than a pattern.
The Real Cardiac Concern: PR Interval Prolongation
The actual cardiac effect of lamotrigine is modest PR interval prolongation (atrioventricular conduction delay), not bradycardia:
- Lamotrigine increases PR interval by approximately 3-4% on average 6
- This occurs in people both with and without heart disease
- Importantly, this increase does not reach pathological levels and is not associated with increased ECG abnormalities 6
- Each 1 μg/mL increase in lamotrigine concentration is associated with a 2.3% increase in PR interval 6
Clinical Decision Algorithm
If you have simple bradycardia (slow heart rate) without other cardiac conditions:
- Lamotrigine is safe to use
- No special cardiac monitoring is required beyond standard care
- The drug does not worsen bradycardia
If you have bradycardia PLUS any of the following:
- Conduction system disease (e.g., first-degree AV block, bundle branch block)
- Structural heart disease
- Heart failure
- Ischemic heart disease
- Taking other medications that affect cardiac conduction
Then you should:
- Obtain a baseline ECG before starting lamotrigine 1
- Monitor for symptoms of worsening conduction (dizziness, syncope, palpitations)
- Consider follow-up ECG after reaching therapeutic dose
- Be aware that concomitant sodium channel blockers increase risk 7
Important Caveats
The psychiatric indication carries different risks: Studies show that psychiatric patients on lamotrigine have higher rates of cardiac events, but this is explained by confounding factors rather than the drug itself 2:
- Greater use of concomitant medications with cardiac effects
- Higher rates of overdose and suicide attempts
- Polypharmacy effects
Bradycardia from reversible causes: According to bradycardia management guidelines, if your bradycardia is due to medications (beta blockers, calcium channel blockers, digoxin), these should be evaluated first 8. Lamotrigine itself is not listed as a cause of bradycardia requiring treatment or discontinuation.
Bottom Line
Bradycardia alone is not a contraindication to lamotrigine use. The FDA warning focuses on patients with structural heart disease and conduction abnormalities who may develop ventricular conduction problems, not bradycardia. If your bradycardia is isolated without underlying conduction system disease, lamotrigine can be safely prescribed. If you have additional cardiac risk factors, obtain baseline and monitoring ECGs, but lamotrigine remains a reasonable option with appropriate surveillance.